377 related articles for article (PubMed ID: 29094049)
1. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Carlomagno N; Incollingo P; Tammaro V; Peluso G; Rupealta N; Chiacchio G; Sandoval Sotelo ML; Minieri G; Pisani A; Riccio E; Sabbatini M; Bracale UM; Calogero A; Dodaro CA; Santangelo M
Biomed Res Int; 2017; 2017():7869802. PubMed ID: 29094049
[TBL] [Abstract][Full Text] [Related]
2. Gastric biomarkers: a global review.
Baniak N; Senger JL; Ahmed S; Kanthan SC; Kanthan R
World J Surg Oncol; 2016 Aug; 14(1):212. PubMed ID: 27514667
[TBL] [Abstract][Full Text] [Related]
3. MET is overexpressed in microsatellite instability-high gastric carcinoma.
Sim J; Heo YJ; Bae H; Shin HC; Kim B; Cho J; Kim ST; Lee J; Kang WK; Kim KM
Pathol Res Pract; 2019 Mar; 215(3):433-438. PubMed ID: 30455128
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
5. Expression and Content of Protein LC3B in Gastric Cancer Tissue, Relationship with Expression of mTOR, AMPK in Gastric Cancer Tissue and HER2 and PD-L1 Status of the Tumor.
Spirina LV; Avgustinovich AV; Afanas'ev SG; Volkov MY; Kondakova IV
Bull Exp Biol Med; 2021 Dec; 172(2):202-205. PubMed ID: 34855092
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
7. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.
Kim C; Mulder K; Spratlin J
Oncologist; 2014 Oct; 19(10):1046-55. PubMed ID: 25142842
[TBL] [Abstract][Full Text] [Related]
8. Current and future biomarkers in gastric cancer.
Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer.
Morihiro T; Kuroda S; Kanaya N; Kakiuchi Y; Kubota T; Aoyama K; Tanaka T; Kikuchi S; Nagasaka T; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
Sci Rep; 2019 Mar; 9(1):4633. PubMed ID: 30874607
[TBL] [Abstract][Full Text] [Related]
11. [Expression level and prognostic value of PD-L1 in microsatellite instability-high gastric cancer].
Wang XY; Hu YJ; Dong K; Zhao C; Huang XZ; Lian SY; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1114-1119. PubMed ID: 33152814
[No Abstract] [Full Text] [Related]
12. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
13. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study.
Beer A; Taghizadeh H; Schiefer AI; Puhr HC; Karner AK; Jomrich G; Schoppmann SF; Kain R; Preusser M; Ilhan-Mutlu A
Pathol Oncol Res; 2020 Oct; 26(4):2225-2235. PubMed ID: 32372174
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
16. Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.
Wang L; Zhang Q; Ni S; Tan C; Cai X; Huang D; Sheng W
Cancer Med; 2018 Jun; 7(6):2612-2620. PubMed ID: 29673110
[TBL] [Abstract][Full Text] [Related]
17. Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents.
Kim HK; Green JE
Pharmacogenomics; 2014 Feb; 15(3):375-84. PubMed ID: 24533716
[TBL] [Abstract][Full Text] [Related]
18. Remnant gastric cancer: a neglected group with high potential for immunotherapy.
Ramos MFKP; Pereira MA; de Castria TB; Ribeiro RRE; Cardili L; de Mello ES; Zilberstein B; Ribeiro-JĂșnior U; Cecconello I
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3373-3383. PubMed ID: 32671505
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and molecular features associated with patient age in gastric cancer.
Seo JY; Jin EH; Jo HJ; Yoon H; Shin CM; Park YS; Kim N; Jung HC; Lee DH
World J Gastroenterol; 2015 Jun; 21(22):6905-13. PubMed ID: 26078567
[TBL] [Abstract][Full Text] [Related]
20. Molecular biomarkers in gastric cancer.
Elimova E; Wadhwa R; Shiozaki H; Sudo K; Estrella JS; Badgwell BD; Das P; Matamoros A; Song S; Ajani JA
J Natl Compr Canc Netw; 2015 Apr; 13(4):e19-29. PubMed ID: 26052595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]